MINNETONKA, Minn. / Aug 23, 2023 / Business Wire / The UnitedHealth Group (NYSE: UNH) board of directors has authorized payment of a cash dividend of $1.88 per share, to be paid on September 19, 2023, to all shareholders of record of UNH common stock as of the close of business September 11, 2023.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow @UnitedHealthGrp on Twitter.
| Last Trade: | US$299.27 |
| Daily Change: | -3.64 -1.20 |
| Daily Volume: | 11,145,209 |
| Market Cap: | US$271.480B |
May 13, 2025 January 16, 2025 October 15, 2024 July 16, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
